SEC Comment Letter 0000000000-23-010047 to HUTCHMED (China) Ltd (HCM)

HUTCHMED (China) Ltd
Date: Sept. 12, 2023 · CIK: 0001648257 · Accession: 0000000000-23-010047

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-37710

Date

September 12, 2023

Author

Johnny Cheng

Form

UPLOAD

Company

HUTCHMED (China) Ltd

Letter

United States securities and exchange commission logo September 12, 2023 Johnny Cheng Chief Financial Officer HUTCHMED (China) Ltd Cheung Kong Center, 48th Floor 2 Queen's Road Central Hong Kong Re:HUTCHMED (China) Ltd Form 20-F for the Year Ended December 31, 2022 Filed February 28, 2023 File No. 001-37710 Dear Johnny Cheng: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
September 12, 2023
Johnny Cheng
Chief Financial Officer
HUTCHMED (China) Ltd
Cheung Kong Center, 48th Floor
2 Queen's Road Central
Hong Kong
Re:HUTCHMED (China) Ltd
Form 20-F for the Year Ended December 31, 2022
Filed February 28, 2023
File No. 001-37710
Dear Johnny Cheng:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io